Generated April 2026 from current fund data.
Overview
JEPI and VYM are both dividend-focused U.S. equity ETFs, but they generate income through fundamentally different mechanisms. JEPI is a covered-call overlay fund that sells call options against S&P 500 exposure to harvest premium income; VYM is a passively managed index fund that tracks high-dividend-yield large-cap stocks. The result is a 356-basis-point spread in yield (8.04% vs. 2.25%) paired with a meaningful difference in upside capture and volatility.
How they differ
JEPI's defining feature is its covered-call strategy, which caps upside in exchange for monthly income. The fund sells calls on the SPX at strikes that historically allow the index to move up before assignment kicks in—but that ceiling means JEPI has logged a beta of 0.54 compared to VYM's 0.77. VYM, by contrast, holds the actual dividend-paying stocks and moves more or less in line with the broad market, capturing gains without artificial income generation.
The yield gap is stark: JEPI distributes 8.04% annually while VYM yields 2.25%. But JEPI's higher payout comes with two caveats. First, covered-call income is vulnerable to call buyback if volatility spikes or the market rallies hard; second, the strategy naturally produces lower price appreciation. VYM's approach is simpler—it owns the stocks, collects their dividends, and lets price growth run. Fees tell a second story: JEPI charges 0.35%, while VYM's index approach costs just 0.04%, a 31-basis-point annual drag on JEPI returns.
AUM favors VYM slightly ($88.7 billion vs. $44 billion), though both funds are large enough for tight liquidity. JEPI has been in existence since May 2020, while VYM has nearly two decades of track record dating to November 2006.
Who each is best for
JEPI: Income-focused investors with a shorter time horizon (5–7 years or less), high current income needs, low risk tolerance for volatility, and a preference for monthly cash flow—ideally in a taxable account where quarterly tax-loss harvesting is impractical.
VYM: Long-term buy-and-hold investors seeking dividend growth coupled with capital appreciation, who are comfortable with quarterly distributions, value simplicity and low fees, and plan to hold for 10+ years in tax-advantaged or taxable accounts alike.
Key risks to know
- Call assignment risk (JEPI): If the S&P 500 rallies sharply, JEPI's calls may be exercised, capping gains and potentially forcing index rebalancing that triggers additional costs or tax consequences.
- NAV erosion potential (JEPI): An 8% yield paired with muted capital appreciation (beta of 0.54) suggests distributions may include meaningful return-of-capital components if underlying equity returns fail to keep pace, eroding the fund's net asset value over a full market cycle.
- Volatility drag (JEPI): The option-selling strategy amplifies losses during sharp downturns, since short calls limit hedging benefits and the fund still owns the equity exposure; JEPI's lower beta masks concentrated downside.
- Interest-rate sensitivity (both): Higher rates typically compress dividend multiples and cap future dividend growth, affecting both funds' total returns, though JEPI's embedded leverage to option volatility adds a secondary risk.
- Tracking and liquidity (VYM): As an index fund, VYM tracks the FTSE High Dividend Yield Index, not the broader market; concentrations in financials and energy historically skew its performance versus the S&P 500.
Bottom line
If you need steady monthly income and accept lower upside capture, JEPI offers an 8% yield with structural simplicity and a respectable $44 billion AUM. If you want broad dividend exposure, long-term growth, and minimal fees, VYM's 2.25% yield, 0.04% expense ratio, and two-decade track record make it a cleaner core holding. Past performance does not predict future results, and the sustainability of JEPI's high yield depends on continued equity markets and sustained option volatility premiums.
AI-generated analysis for educational purposes only. Verify important details independently; past performance does not guarantee future results.